Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:p>The impact of flavonoids on fatigue has not been investigated in relapsing and remitting multiple sclerosis (RRMS).</jats:p><jats:sec><jats:title>Objective</jats:title><jats:p>To determine the feasibility and estimate the potential effect of flavonoid-rich cocoa on fatigue and fatigability in RRMS.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A randomised double-blind placebo-controlled feasibility study in people recently diagnosed with RRMS and fatigue, throughout the Thames Valley, UK (<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="isrctn" xlink:href="69897291">ISRCTN69897291</jats:ext-link>). During a 6-week intervention participants consumed a high or low flavonoid cocoa beverage daily. Fatigue and fatigability were measured at three visits (weeks 0, 3 and 6). Feasibility and fidelity were assessed through recruitment and retention, adherence and a process evaluation.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>40 people with multiple sclerosis (10 men, 30 women, age 44±10 years) were randomised and allocated to high (n=19) or low (n=21) flavonoid groups and included in analysis. Missing data were &lt;20% and adherence to intervention of allocated individuals was &gt;75%. There was a small effect on fatigue (Neuro-QoL: effect size (ES) 0.04, 95% CI −0.40 to 0.48) and a moderate effect on fatigability (6 min walk test: ES 0.45, 95% CI −0.18 to 1.07). There were seven adverse events (four control, three intervention), only one of which was possibly related and it was resolved.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>A flavonoid beverage demonstrates the potential to improve fatigue and fatigability in RRMS.</jats:p></jats:sec>

Original publication

DOI

10.1136/jnnp-2018-319496

Type

Journal article

Journal

Journal of Neurology, Neurosurgery & Psychiatry

Publisher

BMJ

Publication Date

05/2019

Volume

90

Pages

507 - 513